C07D 215/00
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D215/00 (Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems) appears on 7,071 US grants and 6,372 published applications in this corpus.
Search patents in C07D- Granted patents
- 7,071
- Published applications
- 6,372
- Assignees
- 2,505
- Inventors
- 19,124
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 70 | 0 |
| 1977 | 83 | 0 |
| 1978 | 54 | 0 |
| 1979 | 43 | 0 |
| 1980 | 56 | 0 |
| 1981 | 62 | 0 |
| 1982 | 54 | 0 |
| 1983 | 63 | 0 |
| 1984 | 75 | 0 |
| 1985 | 86 | 0 |
| 1986 | 89 | 0 |
| 1987 | 88 | 0 |
| 1988 | 117 | 0 |
| 1989 | 116 | 0 |
| 1990 | 140 | 0 |
| 1991 | 126 | 0 |
| 1992 | 117 | 0 |
| 1993 | 160 | 0 |
| 1994 | 121 | 0 |
| 1995 | 145 | 0 |
| 1996 | 134 | 0 |
| 1997 | 165 | 0 |
| 1998 | 146 | 0 |
| 1999 | 119 | 0 |
| 2000 | 134 | 0 |
| 2001 | 143 | 21 |
| 2002 | 176 | 186 |
| 2003 | 170 | 244 |
| 2004 | 150 | 333 |
| 2005 | 130 | 334 |
| 2006 | 178 | 319 |
| 2007 | 162 | 282 |
| 2008 | 161 | 292 |
| 2009 | 195 | 308 |
| 2010 | 163 | 332 |
| 2011 | 204 | 270 |
| 2012 | 214 | 271 |
| 2013 | 246 | 243 |
| 2014 | 246 | 346 |
| 2015 | 266 | 276 |
| 2016 | 182 | 240 |
| 2017 | 219 | 230 |
| 2018 | 167 | 237 |
| 2019 | 207 | 225 |
| 2020 | 169 | 262 |
| 2021 | 190 | 224 |
| 2022 | 142 | 207 |
| 2023 | 118 | 223 |
| 2024 | 122 | 203 |
| 2025 | 118 | 146 |
| 2026 | 70 | 118 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Crystalline forms of 3-(5,7-difluoro-4-oxo-1,4-dihydroquinolin-2-yl)-4-(methylsulfonyl)benzonitrile8 Oct 2026US 2026/0308126 A1
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Hydroxylamine-based bcr-abl1 inhibitors for treatment of cancer1 Oct 2026US 2026/0297031 A1University of Georgia Research Foundation, Inc.
- Organic compound (oxime) to combat chemical warfare agents1 Oct 2026US 2026/0297032 A1Prepaire Labs Limited
Most cited
By later US patents
- Phosphorescent compounds and devices comprising the same1,017US 6,835,469 B2Universal Display Corporation · 2004
- Material for luminescence element and luminescence element using the same890US 6,528,187 B1Fuji Photo Film Co., Ltd. · 2003
- 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use451US 4,689,338 ARiker Laboratories, Inc. · 1987
- Substituted unsymmetrical cyanine dyes with selected permeability384US 5,658,751 AMolecular Probes, Inc. · 1997
- Cyclic-substituted unsymmetrical cyanine dyes371US 5,436,134 AMolecular Probes, Inc. · 1995